As ELF3 is an inducer of endothelial inflammation10,11,21, ELF3 inhibition may become a crucial strategy for the treatment of hyperglycaemia-mediated endothelial inflammation and injury. This evidence concerns the gene ELF3 and Hyperglycemia.